BIM deletion polymorphism to predict systemic treatment outcome in advanced non-small cell lung cancer

被引：0
|
作者：
Lee, Jih-hsiang
Lin, Yu-lin
Chen, Hsuan-Yu
Chang, Yeun-Chung
Yu, Chong-Jen
Shih, Jin-Yuan
Chen, Kuan-Yu
Yang, Pan-Chyr
Yang, Chih-Hsin
机构：
[1] Natl Taiwan Univ Hosp, Dept Oncol, Taipei, Taiwan
[2] Natl Taiwan Univ Hosp, Taipei, Taiwan
[3] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan
[4] Natl Taiwan Univ Hosp, Coll Med, Taipei, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
8055
引用
收藏
页数：1
相关论文
共 50 条
  • [1] BIM DELETION POLYMORPHISM IN ASIAN AND TREATMENT OUTCOME TO CHEMOTHERAPY IN ADVANCED NON-SMALL CELL LUNG CANCER
    Lee, Jih-Hsiang
    Lin, Yu-Lin
    Hsu, Wei-Hsun
    Chen, Hsuan-Yu
    Chang, Yeun-Chung
    Yu, Chong-Jen
    Shih, Jin-Yuan
    Yang, Pan-Chyr
    Chen, Kuan-Yu
    Yang, James C.
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S333 - S334
  • [2] Clinical significance of BIM deletion polymorphism in chemoradiotherapy for non-small cell lung cancer
    Wakabayashi, Yu
    Masuda, Takeshi
    Fujitaka, Kazunori
    Nakashima, Taku
    Okumoto, Joe
    Shimoji, Kiyofumi
    Nishimura, Yoshifumi
    Yamaguchi, Kakuhiro
    Sakamoto, Shinjiro
    Horimasu, Yasushi
    Miyamoto, Shintaro
    Iwamoto, Hiroshi
    Ohshimo, Shinichiro
    Hamada, Hironobu
    Hattori, Noboru
    CANCER SCIENCE, 2021, 112 (01) : 369 - 379
  • [3] Systemic treatment of advanced non-small cell lung cancer
    Traynor, AM
    Schiller, JH
    DRUGS OF TODAY, 2004, 40 (08) : 697 - 710
  • [4] BIM deletion polymorphism predicts survival in advanced non-small-cell lung cancer
    Zhang, X.
    Zhang, L.
    ANNALS OF ONCOLOGY, 2015, 26 : 143 - 144
  • [5] Clinical significance of BIM deletion polymorphism on chemoradiotherapy in patients with non-small cell lung cancer
    Wakabayashi, Yu
    Masuda, Takeshi
    Sakamoto, Shinjiro
    Fujitaka, Kazunori
    Hamada, Hironobu
    Hattori, Noboru
    CANCER SCIENCE, 2021, 112 : 498 - 498
  • [6] Association between BIM deletion polymorphism and the risk of non-small cell lung cancer in Chinese
    Xia, Jinjing
    Xiong, Liwen
    Chu, Tianqing
    Ye, Junyi
    Bai, Hao
    Yan, Bo
    Zhong, Runbo
    Shao, Minhua
    Han, Baohui
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (05): : 5647 - +
  • [7] Treatment Outcome of Locally Advanced Non-small Cell Lung Cancer
    Lee, Heui Kwan
    Kwon, Hyoung-Cheol
    Lee, Sun Young
    Kim, Jung Soo
    RADIATION ONCOLOGY JOURNAL, 2006, 24 (04): : 237 - 242
  • [8] Systemic treatment of advanced non-small cell lung cancer: controversies and perspectives
    Tiefenbacher A.
    Pirker R.
    memo - Magazine of European Medical Oncology, 2018, 11 (2) : 112 - 115
  • [9] Clinical significance of BIM-deletion polymorphism on chemoradiotherapy in patients with non-small cell lung cancer.
    Wakabayashi, Yu
    Masuda, Takeshi
    Nakashima, Taku
    Fujitaka, Kazunori
    Yamaguchi, Kakuhiro
    Sakamoto, Shinjiro
    Nishimura, Yoshihumi
    Horimasu, Yasushi
    Miyamoto, Shintaro
    Senoo, Tadashi
    Iwamoto, Hiroshi
    Ohshimo, Shinichiro
    Hamada, Hironobu
    Hattori, Noboru
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [10] The treatment of advanced non-small cell lung cancer
    Spiro, SG
    Silvestri, GA
    CURRENT OPINION IN PULMONARY MEDICINE, 2005, 11 (04) : 287 - 291
12345